Human Rhinovirus Infection and Airway Remodeling Mediators
Status:
Terminated
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
In this study, the following subjects will be exposed to human rhinovirus (HRV):
- those with classification of mild-moderate asthma
- healthy control subjects.
The investigators will study the kinetics of HRV-induced inflammatory and remodeling
responses in a well characterized group of asthmatic subjects and compare these outcomes to
those in a healthy, non-asthmatic control group.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator:
Asthma and Allergic Diseases Cooperative Research Centers